The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people
In addition to causing distress and disability to the individual, neuropsychiatric disorders are
also extremely expensive to society and governments. These disorders are both common …
also extremely expensive to society and governments. These disorders are both common …
The prefrontal cortex achieves inhibitory control by facilitating subcortical motor pathway connectivity
CL Rae, LE Hughes, MC Anderson… - Journal of …, 2015 - Soc Neuroscience
Communication between the prefrontal cortex and subcortical nuclei underpins the control
and inhibition of behavior. However, the interactions in such pathways remain controversial …
and inhibition of behavior. However, the interactions in such pathways remain controversial …
Dopaminergic modulation of motor network dynamics in Parkinson's disease
Although characteristic motor symptoms of Parkinson's disease such as bradykinesia
typically improve under dopaminergic medication, deficits in higher motor control are less …
typically improve under dopaminergic medication, deficits in higher motor control are less …
Therapeutic strategies in Parkinson's disease: what we have learned from animal models
Parkinson's disease (PD), the second most common neurodegenerative disorder, is
characterized by a loss of dopaminergic neurons in the substantia nigra, as well as in other …
characterized by a loss of dopaminergic neurons in the substantia nigra, as well as in other …
Guanfacine enhances inhibitory control and attentional shifting in early abstinent cocaine-dependent individuals
Objectives: Attenuation of adrenergic drive and cognitive enhancement, via stimulation of
alpha2 pre-and post-synaptic receptors, may selectively enhance executive performance in …
alpha2 pre-and post-synaptic receptors, may selectively enhance executive performance in …
Monoamine reuptake inhibitors in Parkinson's disease
The motor manifestations of Parkinson's disease (PD) are secondary to a dopamine
deficiency in the striatum. However, the degenerative process in PD is not limited to the …
deficiency in the striatum. However, the degenerative process in PD is not limited to the …
Developments in impulse control behaviours of Parkinson's disease
M Zurowski, JD O'Brien - Current opinion in neurology, 2015 - journals.lww.com
Reduction of dopamine agonist dose is the mainstay of treatment of ICBs. Other forms of
dopaminergic treatment such as deep brain stimulation or jejunal infusion are alternative …
dopaminergic treatment such as deep brain stimulation or jejunal infusion are alternative …
[PDF][PDF] (Dis) Inhibition Imaging Neuropsychiatry in Parkinson's disease
C Vriend - 2015 - research.vumc.nl
Up to 50 percent of all Parkinson's disease (PD) patients develop symptoms of anxiety
during the course of their illness, a percentage that is much higher than in the general …
during the course of their illness, a percentage that is much higher than in the general …